At the intersection of medicine and cutting-edge technology, the broad field of digital health has seen booming valuations in recent months with some big-name investors jumping in. Now, a company working on software-based therapeutics has leaped to unicorn status and will take its show on the road to Nasdaq.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,